Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
PaperCitations, authors & open-access status
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 345 citations, 2019 year and bronze oa status.
345
Citations
2019
Year
bronze
OA Status